Alerts will be sent to your verified email
Verify Email
SMSPHARMA
|
SMS Pharmaceuticals
|
IOL Chem & Pharma
|
Bajaj Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
1.61 % | 0.91 % | 0.35 % |
|
Financials
|
|||
|
5 yr Average ROE
|
9.06 % | 9.87 % | 9.93 % |
|
5yr average Equity Multiplier
|
1.9 | 1.41 | 2.26 |
|
5yr Average Asset Turnover Ratio
|
0.64 | 1.03 | 0.95 |
|
5yr Avg Net Profit Margin
|
7.28 % | 6.75 % | 3.65 % |
|
Price to Book
|
3.41 | 1.12 | 4.76 |
|
P/E
|
29.08 | 19.13 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
93.25 Days | 45.42 Days | 15.4 Days |
|
Inventory Days
|
116.73 Days | 64.41 Days | 51.52 Days |
|
Days Receivable
|
93.46 Days | 83.56 Days | 72.17 Days |
|
Days Payable
|
81.31 Days | 94.27 Days | 83.01 Days |
|
5yr Average Interest Coverage Ratio
|
4.77 | 17.62 | 7.11 |
|
5yr Avg ROCE
|
12.12 % | 13.96 % | 24.2 % |
|
5yr Avg Operating Profit Margin
|
17.98 % | 10.94 % | 16.67 % |
|
5 yr average Debt to Equity
|
0.53 | 0.03 | 0.86 |
|
5yr CAGR Net Profit
|
9.56 % | -4.32 % | n/a |
|
5yr Average Return on Assets
|
4.75 % | 6.97 % | 5.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
64.67 % | 52.62 % | 59.19 % |
|
Share Pledged by Promoters
|
19.4 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.62 % | 8.93 % | -8.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
2.55 % | -0.48 % | 1.64 % |
|
SMS Pharmaceuticals
|
IOL Chem & Pharma
|
Bajaj Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|